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D istal pancreatectomy (DP) is commonly per-formed for the treatment of diseases occurring in 
the body and/or tail of the pancreas.  Although periop-
erative management and operative techniques in pan-
creatic surgery have improved,  post-operative pancre-
atic fistula (POPF) remains the most common 
complication after DP [1].  POPF can be triggered by 
serious incidents such as intra-abdominal abscess and 
intra-abdominal arterial bleeding,  and it can be fatal.  
As such,  identifying patients who are at risk of POPF is 
critical to decrease morbidity after DP and to improve 
clinical outcomes.
A soft pancreas is reported to be a risk factor for 
developing POPF after DP [2-4],  and thus pancreatic 
fibrosis,  which leads to decreased softness of the gland,  
reportedly reduces the risk of POPF.  However,  few 
radiological studies have addressed whether the degree 
of pancreatic fibrosis can be reliably detected and qual-
ified [5 , 6].  Recently,  computed tomography (CT) has 
emerged as a way to objectively identify the pancreatic 
texture preoperatively [7-9].  These reports suggest that 
pancreatic enhancement patterns can be used to assess 
the level of pancreatic fibrosis,  and can thereby serve as 
a tool to predict the risk of POPF after pancreatoduo-
denectomy (PD).  However,  the relevant criteria have 
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Post-operative pancreatic fistula (POPF) remains the most common complication after distal pancreatectomy 
(DP).  In this retrospective study,  we reviewed the data from patients who underwent DP between 2008 and 
2019 in our institute to determine whether the late phase/early phase ratio (L/E ratio) by preoperative computed 
tomography (CT) scan in the pancreas could predict POPF occurrence after DP.  We examined the relationship 
between preoperative or intraoperative factors and the occurrence of POPF after DP using statistical methods in 
23 males and 21 females with a mean age of 73.  The mean L/E ratio was significantly lower in the POPF group 
than the non-POPF group (p= 0.035).  The L/E ratio had moderate diagnostic accuracy,  with a calculated opti-
mal cutoff value of 0.77.  In univariate analysis,  a significant association was noted between POPF and stump 
thickness ≥ 16.9,  body mass index ≥ 27.5,  and L/E ratio ≤ 0.77.  In the multivariate analysis,  the L/E ratio (odds 
ratio,  5.96; p= 0.036) was an independent risk factor for POPF.  Our findings suggest that the pancreatic L/E 
ratio may predict the occurrence of POPF after DP.  This measure may be useful in preoperative risk stratifica-
tion,  patient counseling,  and perioperative patient management,  improving clinical outcomes after DP.
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yet to be defined for patients undergoing DP.
In the present study,  we evaluated the risk factors for 
POPF after DP using both clinical features and preoper-
ative CT values and investigated whether preoperative 
CT values in the pancreas could predict the occurrence 
of POPF after DP.
Materials and Methods
Patients and data collection. Forty-six patients 
who underwent DP at the Department of Surgery in the 
Iwakuni Clinical Center from April 2008 to April 2019 
were consecutively recruited in this study.  After exclud-
ing 2 patients due to a lack of accurate CT data,  the 
remaining 44 patients were included in this study.  To 
evaluate the risk factors for POPF,  we investigated pre-
operative patient data,  including sex,  age,  diabetes,  
alcohol consumption,  smoking status,  body mass index 
(BMI),  controlling nutritional status score [10],  sur-
gery indications,  preoperative serum albumin level,  
main pancreatic duct diameter,  thickness of the stump 
as determined on the preoperative CT.  In addition,  we 
investigated CT attenuation values (late phase/early 
phase [L/E] ratio) in the pancreatic body as described 
below.  The ethics committee at the Iwakuni Clinical 
Center approved the study protocol (approval number:  
0177).  This study is in accordance with the 1975 
Declaration of Helsinki.
CT protocol. CT examination was performed 
using a 320-row multislice CT (Aquilion 320; Cannon 
Medical Systems Corporation,  Tokyo) with the follow-
ing parameters: reconstructed transverse slice thick-
ness of 5 mm,  0.5 sec/rot,  120 kVp,  and pitch factor 
0.813.  The tube current was set to automated exposure 
control.  Each subject was first examined using unen-
hanced CT,  and was then injected with iodinate con-
trast medium (Omnipaque 300; GE Healthcare) using 
a power injector (Nemoto Dual shot GX7).  The injec-
tion dose was 600 mg iodine per kg of body weight,  and 
the duration was fixed at 30 sec; hence,  the injection 
rate depended on the patient’s body weight.
A bolus tracking program was used to optimize the 
scanning delay for arterial scans.  The trigger point was 
located in the abdominal aorta at the level of the celiac 
axis,  and the trigger threshold was set at 150 Hounsfield 
units.  The scan delays were set at 15 s after the trigger 
(about 40 sec after injection),  and a pancreatic (early) 
image was obtained.  Hepatic (late)- and delayed-phase 
images were also obtained about 70 and 180 s after 
injection.  The images were saved in DICOM format 
and transferred to an image workstation using image 
assessment software (EV Insite version 3.3.0.2;  PSP 
Corporation,  Tokyo).
CT evaluation. Two physicians specializing in 
general surgery (MU.  and HA.,  with 15 and 25 years of 
experience,  respectively) who were blinded to the clin-
ical information independently measured the CT atten-
uation values on electronically stored CT images.  CT 
images obtained for diagnostic purposes within 30 days 
before DP were included in this analysis.  CT attenua-
tion values were measured on enhanced images 
obtained in the pancreatic (early) and hepatic (late) 
phases after contrast administration.  CT attenuation 
values of the pancreatic parenchyma were quantified 
using Hounsfield unit thresholds by determining the 
region of interest (ROI) in two points in two segments 
of the head of the pancreas,  which is proximal to the 
planned resection line (Fig. 1).  The mean value for the 
two segments was computed for each patient.  The larg-
est possible spherical ROI was placed so as to avoid the 
pancreatic duct and extrapancreatic structures.  The 
smallest ROI measured was approximately 3 mm in 
diameter in a patient with atrophic pancreas.  The 
enhancement ratio expressed as the L/E ratio was calcu-
lated as (hepatic phase − unenhanced phase)/(pancre-
atic phase − unenhanced phase) to indicate delayed-
phase enhancement.  The L/E ratio at the pancreatic 
body was used to assess pancreatic firmness.
Operative procedure. All surgeries were per-
formed by a pancreatic surgeon with more than 15 years 
of experience.  The pancreatic thickness of the pancre-
atic cutting line was measured by intraoperative ultra-
sonography and preoperative CT.  In cases with a pan-
creatic cutting line of ≤ approximately 15 mm thickness,  
the pancreas tended to be divided using Endo GIATM 
Reload with Tri-StapleTM.  The Cartridge height of the 
stapler was selected according to the thickness of the 
pancreatic cutting line.  In cases with a pancreatic cut-
ting line of ≥ approximately 15 mm thickness,  the pan-
creas was cut using a scalpel,  and the pancreatic duct 
was identified and ligated.  The cut edge of the pancreas 
was sutured using 4-0 absorbable monofilament and a 
fish-mouth closure.  The omentum was left between the 
pancreatic stump and major arteries,  including the 
celiac artery or common hepatic artery,  to prevent 
aneurysms.  Two closed suction drains were placed at 
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the pancreatic stump and left in the subphrenic space.  
Prophylactic antibiotics were administered for 3 days 
after surgery.  Somatostatin analogues were not used for 
the prevention of POPF in any patient.
Classification and detailed definition of POPF.
POPF was diagnosed and graded based on the 
International Study Group on Pancreatic Fistula classi-
fication [11].  POPF was diagnosed when the amylase 
concentration in the drainage fluid on postoperative 
day 3 was more than three times the upper limit of its 
normal serum concentration.  Grade A POPF is bio-
chemical fistula,  and it was defined as measurable fluid 
output on or after postoperative day 3,  with amylase 
content higher than three times the upper normal 
serum level.  Grade A POPF has no clinical impact on 
the normal postoperative pathway.  Clinically significant 
POPFs are classified as grades B and C.  POPF with an 
elevated inflammatory response observed in blood 
examination and following intravenous antibiotic 
administration was defined as grade B POPF caused by 
infection.  POPF that required drain placement for > 22 
days and showed no elevated inflammatory response or 
did not require antibiotic administration was defined as 
grade B POPF caused by long-term drain placement.  
Whenever a major change in clinical management or 
deviation from the normal clinical pathway was 
required or organ failure occurred,  the fistula was clas-
sified as grade C POPF.
Pathologic evaluation. Histologic evaluation of 
the pancreatic surgical specimens stained by hematoxy-
lin-eosin was performed by an experienced pathologist 
who was blinded to the radiological findings and clini-
cal data (YS,  with 17 years of experience in pathology).  
Pancreatic fibrosis at the resection margin was graded 
as: F0,  normal parenchyma with no fibrotic change;  
F1,  mild fibrosis with thickening of periductal fibrosis;  
F2,  moderate fibrosis with marked sclerosis of the 
interlobular septa and no evidence of architectural 
change; and F3,  severe fibrosis with architectural dis-
ruption [12].  Two patients were excluded owing to lack 
of pathological data.  Therefore,  data from the patho-
logic evaluation of 42 patients were analyzed.
Statistical analysis. Statistical analyses were per-
formed using the unpaired Student’s t-test and χ2 test 
with Fisher’s exact test.  All variables were assessed 
using univariate analyses,  and only those showing sta-
tistical significance (p < 0.05) were evaluated using mul-
tivariate logistic analyses to determine the primary 
independent risk factors for POPF.  Values of p < 0.05 
were considered statistically significant.  Diagnostic 
accuracy was determined by the area under the curve 
(AUC).  The optimal cutoff values were determined by 
maximizing the Youden index (sensitivity + specific-
ity − 1) [13].  Pearson r correlation coefficient was calcu-
lated between computed tomography enhancement 
ratio (late phase/early phase ratio) and pancreatic fibro-
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???? ?　 Measurement of the late phase to early phase ratio.  Computed tomography (CT) attenuation values were measured on enhanced 
images obtained in the pancreatic (early) and hepatic (late) phases after contrast administration.  CT attenuation values of the pancreatic 
parenchyma were quantified using Hounsfield unit thresholds by placing a region of interest in the pancreas body.  The enhancement ratio 
expressed as the late phase/early phase ratio (L/E ratio) was calculated as (hepatic phase－unenhanced phase)/(pancreatic phase－
unenhanced phase) to indicate delayed-phase enhancement.
L/E ratio= (late phase-unenhanced phase)/(early phase‒unenhanced phase)=109.6－56.5/146.4－56.5=0.59.
sis by histology.  Statistical analysis was performed 
using JMP version 9 software (SAS Institute,  Cary,  NC,  
USA).
Results
Patient characteristics. The demographics and 
clinical characteristics of our cohort are summarized in 
Table 1.  There were 23 males and 21 females,  with a 
mean age of 73 years (range: 44-85 years).  The most 
frequently observed indication for DP was pancreatic 
ductal carcinoma (17 patients; 38.6%).  Of the 44 
patients,  15 patients (34.1%) developed Grade B POPF.  
No patient developed grade C POPF,  and the postoper-
ative mortality was 0%.  Patients with grade B POPF 
constituted the POPF group for this study.  The non-
POPF group consisted of the 29 remaining patients 
(non-POPF or grade A POPF).  Table 2 shows a com-
parison of the two groups.  No differences were 
observed in sex,  age,  indication of surgery,  drinking 
history,  smoking history,  preoperative diabetes,  pre-
operative serum albumin level,  and/or anticoagulant 
therapy.
Intra- and perioperative findings. The mean 
postoperative length of hospital stay (LOS) for the 
POPF group was 45 ± 6 days,  which was significantly 
longer than that of the non-POPF group with a mean 
LOS of 22 ± 3 days (p = 0.005).  No differences were 
observed in operation time,  blood loss,  method of clo-
sure,  diameter of the main pancreatic duct,  laparo-
scopic surgery,  transfusion,  and/or thickness of the 
stump.
CT assessment. In the POPF group,  the pancre-
atic parenchyma showed maximum enhancement in the 
pancreatic phrase and washout in the hepatic phase.  In 
contrast,  in the non-POPF group,  the pancreas showed 
decreased enhancement in the pancreatic phase and 
maintained higher attenuation values in the hepatic 
phase,  consistent with a delayed enhancement pattern.  
Therefore,  the mean value of the L/E ratio was signifi-
cantly lower in the POPF group than in the non-POPF 
group (0.61 ± 0.21,  95% confidence interval [CI]:  
0.48-0.73 vs. 0.79 ± 0.27,  95% CI: 0.68-0.90; p = 0.035).  
The diagnostic accuracy of the L/E ratio for the occur-
rence of POPF was evaluated by the AUC,  as shown in 
Fig. 2.  The L/E ratio had moderate diagnostic accuracy 
(AUC: 0.703),  with a calculated optimal cutoff value of 
0.77.  Using this cutoff value,  the sensitivity and speci-
ficity of the L/E ratio for POPF were 0.857 and 0.593,  
respectively.
Univariate and multivariate analyses for POPF.
The results of the univariate and multivariate analyses 
for POPF are shown in Table 2 and 3.  A significant 
association was noted between POPF and each of fol-
lowing: stump thickness ≥ 16.9 (p = 0.039),  BMI ≥ 27.5 
(p = 0.033),  and L/E ratio ≤ 0.77 (p = 0.018).  The signif-
icant preoperative risk factors for POPF that were iden-
tified using the univariate analysis were incorporated 
into a multivariate logistic regression analysis.  The 
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????? ?　 Patient characteristics
Characteristics n=44
Preoperative
　Mean age (years) 72.0±8.2
　Sex (male/female) 23/21
　BMI (kg/m2) 21.2±4.2
　Indication of surgery
　 Pancreatic cancer 17
　 IPMN 13
　 Metastatic tumor 4
　 Chronic pancreatitis 2
　 Others (AIP,  NET,  trauma,  GC) 8
　CONUT score 1.9±1.6
　Drinking history 21
　Smoking history 20
　Preoperative serum albumin level (g/dL) 4.01±0.42
　Preoperative diabetes 10
　Anticoagulant therapy 6
　Enhanced CT values
　 Late/Early ratio 0.73±0.27
　Unenhanced CT value
　　 MPD (mm) 2.9±2.1
　 Thickness of the stump (mm) 12.6±4.2
Intraoperative
　Laparoscopic surgery 7
　Operative time (min) 358±128
　Blood loss (mL) 723±90
　Method of closure by Stapler 13
　Transfusion 2
Postoperative
　POPF (Grade B/Grade C) 15/0
　Duration of in-hospital day 32±20
　In-hospital mortality 0
　Fibrosis (F0/F1/F2/F3) 11/15/9/7
BMI,  body mass index; AIP,  autoimmune pancreatitis; NET,  neu-
roendocrine tumor; GC,  gastric cancer; CONUT,  controlling nutri-
tional status; MPD,  main pancreatic duct; POPF,  postoperative 
pancreatic fistula.
Values are presented as mean±standard deviation with 95% con-
fidence interval or number of patients.
results showed that the L/E ratio (OR: 5.96; p = 0.036) 
was an independent risk factor for POPF.
Pancreatic fibrosis. The degree of fibrosis was 
significantly lower in the POPF group than the non-
POPF group (p = 0.001).  Pancreatic fibrosis demon-
strated a weak positive correlation with the L/E ratio 
(Fig. 3) (r = 0.480; p = 0.002).
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????? ?　 Comparison of patient characteristics for the POPF group and non-POPF group
POPF group
(n=15)
Non-POPF
group (n=29) P value
　Mean age (years) 71.3±7.4 71.5±8.8 0.872
　Sex (male/female) 10/6 14/14 0.460
　BMI (kg/m2) 21.6±4.8 20.5±3.8 0.408
　Indication of surgery 0.339
　 Pancreatic cancer 6 11
　 IPMN 4 9
　 Metastatic tumor 1 3
　 Chronic pancreatitis 1 1
　 Others (AIP,  NET,  trauma,  GC) 3 5
　CONUT score 2.1±1.9 1.8±1.5 0.561
　Drinking history 9 10 0.151
　Smoking history 7 12 0.889
　Preoperative serum albumin level (g/dL) 4.0±0.4 4.0±0.5 0.721
　Preoperative diabetes 4 5 0.542
　Anticoagulant therapy 2 3 0.721
　Enhanced CT values 
　 Late/Early ratio 0.61±0.21 0.79±0.27 0.035
　Unenhanced CT value
　 MPD (mm) 2±0.9 3.1±2.5 0.642
　 Thickness of the stump (mm) 13.9±4.3 11.7±4.0 0.119
??????????????
　Laparoscopic surgery 2 5 0.661
　Operative time (min) 348±32 363±26 0.732
　Blood loss (mL) 724±146 643±91 0.628
　Method of closure by Stapler 10 19 0.804
　Transfusion 1 1 0.672
?????????????
　Duration of in-hospital day 45±6 22±3 0.005
　Fibrosis (F0/F1/F2/F3) 8/7/1/0 3/8/8/7 0.001
BMI,  body mass index; AIP,  autoimmune pancreatitis; NET,  neuroendocrine tumor; GC,  gastric cancer; CONUT,  controlling nutritional 
status; MPD,  main pancreatic duct; POPF,  postoperative pancreatic fistula.
Values are presented as mean±standard deviation with 95% confidence interval or number of patients.
????? ?　 Univariate and multivariate analyses: independent risk factors for POPF
Univariate analysis Multivariate analysis
Odds ratio (95% CI) p value Odds ratio (95% CI) p value
BMI ≥27.5 kg/m2 9.00 (0.907-89.26) 0.033 11.89 (0.959-341.1) 0.054
Late/Early ratio ≤0.77 5.33 (1.202-23.66) 0.018 5.96 (1.117-49.17) 0.036
Preoperative serum albumin level ≤3.8 (g/dL) 3.89 (0.731-20.68) 0.083 1.32 (0.171-12.83) 0.788
Thickness of the stump ≥16.9 mm 5.91 (0.991-35.21) 0.039 2.03 (0.213-22.49) 0.528
CI,  confidence interval; BMI,  body mass index; POPF,  postoperative pancreatic fistula.
Discussion
This retrospective analysis revealed that a low L/E 
ratio by pancreatic CT scan,  indicating a soft pancreas,  
was an independent predictor of POPF after DP.  The 
texture of the pancreatic parenchyma is generally con-
sidered one of the most important risk factors for the 
increased incidence of pancreatic fistula [2-4].  Fibrotic 
pancreatic tissue is considered less likely to result in 
pancreatic leakage.  Reduced firmness of the pancreas is 
considered a risk factor for POPF [2-4].
Despite the importance of this parameter,  pancre-
atic firmness assessed solely by the surgeon during sur-
gery may not be accurate.  The distinction between the 
end of the soft area and beginning of the firm area is 
obscure,  and a widely accepted definition of pancreatic 
texture is lacking.  Pancreatic fibrosis increases the 
firmness of the gland.  Hashimoto et al.  reported that 
the ratio of the mean pancreatic CT attenuation value 
(hepatic to pancreatic phase; L/E ratio) upstream from 
the tumor may assist in the histologic assessment of the 
degree of pancreatic fibrosis [7].  In accordance with the 
literature,  we observed that patients with a low L/E 
ratio by pancreatic CT had a higher incidence of pan-
creatic leakage than those with a high L/E ratio,  indi-
cating fibrotic pancreatic parenchyma.
Previous studies described the utility of CT data to 
determine the risk of POPF after PD [7-9].  There is a 
difference between POPF after PD and that after DP.  
While POPF after PD is caused by leakage of pancreato-
jejunostomy,  POPF after DP is caused by leakage of the 
stump of the remnant pancreas.  We considered that the 
risk factors for POPF would also differ between patients 
post-PD and post-DP.
In our study,  grade B POPF after DP occurred in 15 
patients (34.1%); this incidence was higher than that in 
a recent report [1].  Differences in the patient popula-
tions,  such as a higher proportion of elderly patients,  
may partly explain this discrepancy.  In addition,  we 
previously tended to place the drainage tube for a long 
duration regardless of infection or POPF,  which may be 
another reason for the high incidence of POPF in this 
study.
Various risk factors for POPF after DP have been 
reported,  including male [14 , 15],  older age [16-18],  
high BMI [14 , 15 , 17],  diabetes mellitus [17 , 19],  car-
tridge size [20],  pancreatic thickness [15-17],  chronic 
pancreatitis [21],  extended lymphadenectomy [18],  and 
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duration of operation [19 , 22].  In this study,  we 
observed that POPF development was not affected by 
any patient-specific,  surgical,  or tumor-related factors,  
other than pancreatic findings as determined by CT 
imaging.
As mentioned above,  pancreatic texture is an 
important factor for POPF after DP.  However,  it is not 
possible to determine the texture by intraoperative pal-
pation alone.  Although elastography using ultrasound 
is one way to determine preoperative pancreatic stiff-
ness [23],  it is not commonly used due to some limita-
tions [23 , 24].  On the other hand,  it has been shown 
that the L/E ratio determined by dual-phase CT scan is 
a good indicator of the level of fibrosis in the pancreas 
[7].  Considering that CT scans are more objective and 
more readily available,  we believe that the enhance-
ment characteristics on preoperative dual-phase pan-
creatic CT scans are a more reliable index of the firm-
ness of the pancreas,  and as such,  of the risk of 
developing POPF after DP.  It has been reported that a 
fibrotic pancreas leads to reduced exocrine activity [25] 
and less pancreatic juice,  which may reduce the risk of 
POPF.  Hence,  determining the firmness of the pan-
creas preoperatively can determine the risk of develop-
ing POPF prior to DP.  In our study,  the histologic 
degree of pancreatic fibrosis showed correlation with the 
L/E ratio.  Further,  pancreatic fibrosis was associated 
with the occurrence of POPF after DP.  Thus,  these data 
suggest that calculating the L/E ratio may be a useful 
and noninvasive way to assess pancreatic fibrosis preop-
eratively and stratify the patients who are at a risk of 
POPF.
Pancreatic fibrosis is one of the characteristics of 
chronic pancreatitis.  The risk factors of chronic pancre-
atitis are reported as alcohol use,  smoking,  and auto-
immune and genetic factors [26].  We analyzed whether 
the preoperative clinical factors were associated with the 
degree of pancreatic fibrosis.  However,  no significant 
factor was associated with the L/E ratio (data not 
shown).
Although to the best of our knowledge,  this study is 
the first to describe the assessment of enhancement 
characteristics on preoperative dual-phase pancreatic 
CT as a method to estimate the risk of developing POPF 
after DP,  it has several limitations,  including its retro-
spective design and limited sample size.  Further studies 
are necessary to gain more insight into these associa-
tions.
In conclusions,  a low L/E ratio by pancreatic CT 
scan was found to be an independent risk factor for 
POPF after DP.  The results of this study suggest that the 
risk of clinically relevant POPF can be predicted by 
measuring pancreatic parenchyma CT values.  
Therefore,  CT enhancement characteristics of the pan-
creas may be useful in preoperative risk stratification,  
patient counseling,  and perioperative patient manage-
ment,  which will ultimately result in better clinical 
outcomes after DP.
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